The mechanism for amyloid formation in a model peptide
The mechanism for amyloid formation in a model peptide
批准号:
BB/D000718/1
负责人:
David John Wales
金额:
$28.46万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Proteins are chains constructed from twenty different amino acids, which must fold up into a biologically active form after they are synthesised in cells. The functional proteins play essential structural and catalytic roles in all living organisms. However, when proteins misfold they can form well-defined aggregates, generically known as amyloid, and it is now known that a wide variety of proteins can be induced to form amyloid under appropriate conditions. Amyloid formation has been implicated in a number of serious diseases, such as Alzheimer's (senile dementia), bovine spongiform encephalopathy (mad cow disease), and Creutzfeld-Jacob disease (the human form of mad cow disease). It is also associated with diabetic conditions caused by poorly chosen diets, as well as inherited traits, such as early onset forms of dementia. The realisation that aggregation can occur for a wide range of proteins under suitable conditions is relatively recent, and many fundamental questions concerning amyloid formation are still unresolved. Although there is general agreement that aggregation is induced by a conformational change from the native structure to a generic sheet-like structure (related to that in silk), little is known about the mechanistic details of this process, and discovering how it occurs is a key priority for the development of treatment for amyloid diseases. The conformational change appears to be self-propagating, since the rate increases as the reaction progresses. The goal of this project is to elucidate the mechanism by which the structure changes from a compact state into amyloid for a recently designed artificial protein. We aim to resolve this mechanism at an atomic level of detail using newly developed theory and computer simulation techniques. The results will provide important new insights into amyloid formation. In particular, more specific and precise methods to prevent and perhaps reverse amyloid formation may emerge, with important implications for the treatment of human disease, including aspects of ageing and conditions related to obesity and poorly chosen diets.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Free energy surfaces from an extended harmonic superposition approach and kinetics for alanine dipeptide
丙氨酸二肽的扩展谐波叠加方法和动力学的自由能表面
DOI:
10.1016/j.cplett.2008.10.085
发表时间:
2008
期刊:
Chemical Physics Letters
影响因子:
2.8
作者:
[Strodel B]
通讯作者:
Strodel B
Erratum: Symmetrization of the AMBER and CHARMM force fields [J. Comp. Chem. 31, 1402]
勘误表:AMBER 和 CHARMM 力场的对称性 [J。
DOI:
10.1002/jcc.23064
发表时间:
2012
期刊:
Journal of Computational Chemistry
影响因子:
3
作者:
[Malolepsza E]
通讯作者:
Malolepsza E
Implicit Solvent Models and the Energy Landscape for Aggregation of the Amyloidogenic KFFE Peptide.
淀粉样蛋白 KFFE 肽聚集的隐式溶剂模型和能量景观。
DOI:
10.1021/ct700305w
发表时间:
2008
期刊:
Journal of chemical theory and computation
影响因子:
5.5
作者:
[Strodel B]
通讯作者:
Strodel B
Characterizing the first steps of amyloid formation for the ccbeta peptide.
表征 ccbeta 肽淀粉样蛋白形成的第一步。
DOI:
10.1021/jp801222x
发表时间:
2008
期刊:
The journal of physical chemistry. B
影响因子:
--
作者:
[Strodel B]
通讯作者:
Strodel B
Transmembrane structures for Alzheimer's Aß(1-42) oligomers.
阿尔茨海默病 Aα(1-42) 寡聚物的跨膜结构。
DOI:
10.1021/ja103725c
发表时间:
2010
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Strodel B]
通讯作者:
Strodel B
Intrinsically Multifunctional Energy Landscapes: A New Paradigm for Molecular Design
-
批准号:EP/N035003/1
-
项目类别:Research Grant
-
资助金额:$127.52万
-
财政年份:2016
-
负责人:David John Wales
-
依托单位:
TOUCAN: TOwards an Understanding of CAtalysis on Nanoalloys
-
批准号:EP/J010847/1
-
项目类别:Research Grant
-
资助金额:$68.03万
-
财政年份:2012
-
负责人:David John Wales
-
依托单位:
Characterising and Controlling Rare Event Dynamics
-
批准号:EP/H042660/1
-
项目类别:Research Grant
-
资助金额:$59.68万
-
财政年份:2010
-
负责人:David John Wales
-
依托单位:
Conformational changes in proteins: rates and mechanisms from discrete path sampling
-
批准号:BB/D010276/1
-
项目类别:Research Grant
-
资助金额:$25.27万
-
财政年份:2006
-
负责人:David John Wales
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
APOC1,CLU,SORL1,APOE变异通过调控脂代谢和Abeta水平影响痴呆发病机理的研究
-
批准号:81460203
-
项目类别:地区科学基金项目
-
资助金额:47.0万元
-
批准年份:2014
-
负责人:胡才友
-
依托单位:
TAG1/APP信号通路调控的miRNA及其在神经前体细胞增殖和分化中的作用机制
-
批准号:31171313
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:马全红
-
依托单位:
细胞型朊蛋白介导Aβ寡聚体神经毒性的信号转导机制研究
-
批准号:81100246
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:张海英
-
依托单位:
EndophilinB1对APP及A-beta的调控作用在阿尔茨海默病中的机制性研究
-
批准号:81171017
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:万峻
-
依托单位:
STAT3对miRNA-200家族的转录调控作用在阿尔茨海默病发病机理中的功能性研究
-
批准号:81000465
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:万峻
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
天然药物诱导神经元NEP表达上调及降低Aβ缓解Alzheimer症作用机制的研究
-
批准号:30670746
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2006
-
负责人:崔行
-
依托单位: